Laurus Labs gets EIR for API manufacturing facility in Andhra Pradesh

15 Apr 2025 Evaluate

Laurus Labs has received the Establishment Inspection Report (EIR) for its API manufacturing facility Unit-4, Atchutapuram, Anakapalli District (Visakhapatnam), Andhra Pradesh. The United States Food & Drug Administration (USFDA) inspection was conducted from January 27, 2025 to January 31, 2025. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas. 

Laurus Labs Share Price

1018.10 -0.10 (-0.01%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×